Medical disclaimer: Melasma is a chronic condition with a hormonal component that often requires prescription treatment. This page covers OTC management strategies. Consult a dermatologist for moderate-to-severe melasma.

Hyperpigmentation and melasma are often grouped together — but they have different causes, different triggers, and different treatment hierarchies. Using the wrong approach for the wrong type wastes months of effort. This protocol distinguishes between them and provides a targeted ingredient strategy for each.

Hyperpigmentation vs. Melasma: The Critical Distinction

Post-Inflammatory Hyperpigmentation (PIH)

PIH is triggered by skin injury or inflammation — acne, eczema, cuts, burns, or any trauma that triggers melanin overproduction as part of the healing response. It is not hormonally driven. It responds well to topical brightening actives and SPF. See also Post-Acne Scar Protocol.

Solar Lentigines (Sun Spots / Age Spots)

Caused by cumulative UV exposure. Appear on sun-exposed areas (face, hands, décolleté). Respond to brightening actives + SPF; more resistant than PIH. In-office treatments (IPL, laser) are most effective for established spots.

Melasma

Melasma is a chronic, hormonally influenced condition characterized by symmetric brown or gray-brown patches, typically on the cheeks, forehead, upper lip, and chin. It is triggered or worsened by UV exposure, hormonal changes (pregnancy, oral contraceptives, HRT), and heat. It is significantly more treatment-resistant than PIH or solar lentigines because the melanocytes are chronically activated — not just responding to a single injury. SPF is the most important intervention; without it, all other treatments fail.

Evidence by Ingredient

🟢 TIER 1 — Multiple RCTs Confirm

Tranexamic Acid (TXA)

The most evidence-supported OTC ingredient specifically for melasma. TXA inhibits the interaction between keratinocytes and melanocytes, reducing melanin production at the source. Ebrahimi & Naeini (2014), Journal of Research in Medical Sciences, PMID 25097630, demonstrated 3% topical TXA was as effective as 3% hydroquinone for melasma with fewer side effects. Optimal concentration: 2–5% topical.

Niacinamide (4–10%)

Inhibits melanosome transfer from melanocytes to keratinocytes — reducing visible pigmentation without affecting melanin synthesis directly. Hakozaki et al. (2002), British Journal of Dermatology, PMID 12100180. Effective for both PIH and melasma; well-tolerated on all skin types.

Vitamin C (L-Ascorbic Acid, 10–20%)

Inhibits tyrosinase (the enzyme that catalyzes melanin synthesis) and provides antioxidant protection against UV-induced melanogenesis. Telang (2013), Indian Dermatology Online Journal, PMID 23741676. Stability is the key challenge — L-ascorbic acid oxidizes rapidly; use fresh, opaque packaging. See Vitamin C Serum Guide.

SPF 50+ (Daily, Non-Negotiable)

UV exposure is the primary trigger for both melasma and solar lentigines. Without daily SPF, all other treatments are undermined. For melasma specifically, even incidental UV exposure (through windows, on cloudy days) can trigger recurrence. Tinted SPF with iron oxides provides additional protection against visible light, which also triggers melasma. This is the single most important step in this entire protocol.

🟡 TIER 2 — Promising Evidence

Azelaic Acid (10–20%)

Inhibits tyrosinase selectively in hyperactive melanocytes — making it particularly useful for PIH and melasma without affecting normal skin pigmentation. Gollnick et al. (1996), JEADV, PMID 8987015. Well-tolerated on sensitive skin; safe in pregnancy (unlike hydroquinone and retinoids).

Kojic Acid (1–2%)

Tyrosinase inhibitor derived from fungi. Multiple studies confirm efficacy for hyperpigmentation; less evidence than TXA or niacinamide for melasma specifically. Can cause contact dermatitis in some individuals — patch test first.

Retinoids

Accelerate cell turnover, dispersing melanin-containing cells faster. Effective for PIH and solar lentigines; less effective for melasma alone (best used in combination with TXA or niacinamide). Increase photosensitivity — evening use only, mandatory SPF.

What Does NOT Work for Melasma

Honest limitations: melasma is a chronic condition — it can be managed but not cured with OTC products. Heat (hot yoga, saunas, steam rooms) triggers melasma independently of UV — avoid during active treatment. Laser and IPL can worsen melasma if not performed by an experienced provider — post-inflammatory hyperpigmentation from the procedure itself is a real risk. Hydroquinone (prescription) is the gold standard but requires medical supervision and should not be used long-term without breaks.

The Hyperpigmentation & Melasma Protocol

Timeline & Expectations

PIH: 3–6 months with consistent protocol. Solar lentigines: 6–12 months; in-office treatment significantly faster. Melasma: indefinite management — improvement in 3–6 months, but recurrence is common without ongoing SPF and trigger avoidance. Patience and consistency are the variables that determine outcomes.

Related Protocols

• Brightening & Dark Spot Protocol
• Post-Acne Scar Protocol
• Vitamin C Serum Guide
• Mineral Sunscreen Guide
• Perimenopause Skin Protocol
• The Complete Veracil Skincare System

Commercial disclosure: Veracil sells skincare products including some referenced in this protocol. All recommendations are based on clinical evidence and protocol compatibility.